Difference between revisions of "Template:Chemotherapeutic agents"
Jump to navigation
Jump to search
imported>Whywhenwhohow (add Padeliporfin) |
imported>Whywhenwhohow (sort entries) |
||
Line 12: | Line 12: | ||
* ''[[Catharanthus#Vinca alkaloids|Vinca alkaloid]]s'' ([[Vinblastine]]<sup>#</sup> | * ''[[Catharanthus#Vinca alkaloids|Vinca alkaloid]]s'' ([[Vinblastine]]<sup>#</sup> | ||
* [[Vincristine]]<sup>#</sup> | * [[Vincristine]]<sup>#</sup> | ||
+ | * [[Vindesine]] | ||
* [[Vinflunine]]<sup>§</sup> | * [[Vinflunine]]<sup>§</sup> | ||
− | |||
* [[Vinorelbine]]<sup>#</sup>) | * [[Vinorelbine]]<sup>#</sup>) | ||
Line 40: | Line 40: | ||
* [[Pemetrexed]] | * [[Pemetrexed]] | ||
* [[Pralatrexate]]) | * [[Pralatrexate]]) | ||
− | * ''[[Thymidylate synthase inhibitor]]'' ([[ | + | * ''[[Thymidylate synthase inhibitor]]'' ([[Pemetrexed]] |
− | * [[ | + | * [[Raltitrexed]]) |
| group2 = [[Purine analogue|Purine]] | | group2 = [[Purine analogue|Purine]] | ||
Line 52: | Line 52: | ||
* [[Nelarabine]] | * [[Nelarabine]] | ||
− | * ''[[Thiopurine]]'' ([[ | + | * ''[[Thiopurine]]'' ([[Mercaptopurine]]<sup>#</sup> |
− | * [[ | + | * [[Tioguanine]]<sup>#</sup>) |
| group3 = [[Pyrimidine analogue|Pyrimidine]] | | group3 = [[Pyrimidine analogue|Pyrimidine]] | ||
| list3 = | | list3 = | ||
− | * ''[[Thymidylate synthase inhibitor]]'' ([[ | + | * ''[[Thymidylate synthase inhibitor]]'' ([[Capecitabine]]<sup>#</sup> |
− | * [[ | + | * [[Carmofur]] |
* [[Doxifluridine]] | * [[Doxifluridine]] | ||
− | * [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]]) | + | * [[Floxuridine]] |
− | + | * [[Fluorouracil]]<sup>#</sup> | |
− | + | * [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]])) | |
* ''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]<sup>#</sup>) | * ''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]<sup>#</sup>) | ||
Line 82: | Line 82: | ||
| group1 = [[Type I topoisomerase#Inhibition|I]] | | group1 = [[Type I topoisomerase#Inhibition|I]] | ||
| list1 = | | list1 = | ||
− | * ''[[Camptotheca]]'' ([[Camptothecin]] | + | * ''[[Camptotheca]]'' ([[Belotecan]] |
+ | * [[Camptothecin]] | ||
* [[Cositecan]]<sup>†</sup> | * [[Cositecan]]<sup>†</sup> | ||
− | * [[ | + | * [[Exatecan]] |
* [[Gimatecan]] | * [[Gimatecan]] | ||
− | |||
* [[Irinotecan]]<sup>#</sup> | * [[Irinotecan]]<sup>#</sup> | ||
* [[Lurtotecan]]<sup>‡</sup> | * [[Lurtotecan]]<sup>‡</sup> | ||
+ | * [[Rubitecan]]<sup>‡</sup> | ||
* [[Silatecan]]<sup>§</sup> | * [[Silatecan]]<sup>§</sup> | ||
− | * [[Topotecan]] | + | * [[Topotecan]]) |
− | |||
| group2 = [[Type II topoisomerase#Inhibition|II]] | | group2 = [[Type II topoisomerase#Inhibition|II]] | ||
Line 101: | Line 101: | ||
| list3 = | | list3 = | ||
* ''[[Anthracycline]]s'' ([[Aclarubicin]] | * ''[[Anthracycline]]s'' ([[Aclarubicin]] | ||
+ | * [[Amrubicin]]<sup>†</sup> | ||
* [[Daunorubicin]]<sup>#</sup> | * [[Daunorubicin]]<sup>#</sup> | ||
* [[Doxorubicin]]<sup>#</sup> | * [[Doxorubicin]]<sup>#</sup> | ||
* [[Epirubicin]] | * [[Epirubicin]] | ||
* [[Idarubicin]] | * [[Idarubicin]] | ||
− | |||
* [[Pirarubicin]] | * [[Pirarubicin]] | ||
* [[Valrubicin]] | * [[Valrubicin]] | ||
Line 120: | Line 120: | ||
| group1 = [[Alkylating antineoplastic agent|Alkylating]] | | group1 = [[Alkylating antineoplastic agent|Alkylating]] | ||
| list1 = | | list1 = | ||
− | * ''[[Nitrogen mustard]]s:'' [[Chlormethine]] | + | * ''[[Nitrogen mustard]]s:'' [[Bendamustine]]<sup>#</sup> |
+ | * [[Chlormethine]] | ||
* [[Cyclophosphamide]]<sup>#</sup> ([[Ifosfamide]]<sup>#</sup> | * [[Cyclophosphamide]]<sup>#</sup> ([[Ifosfamide]]<sup>#</sup> | ||
* [[Trofosfamide]]) | * [[Trofosfamide]]) | ||
* [[Chlorambucil]]<sup>#</sup> ([[Melphalan]] | * [[Chlorambucil]]<sup>#</sup> ([[Melphalan]] | ||
* [[Prednimustine]]) | * [[Prednimustine]]) | ||
− | |||
* [[Uramustine]] | * [[Uramustine]] | ||
* ''[[Nitrosourea]]s:'' [[Carmustine]] | * ''[[Nitrosourea]]s:'' [[Carmustine]] | ||
+ | * [[Fotemustine]] | ||
* [[Lomustine]] ([[Semustine]]) | * [[Lomustine]] ([[Semustine]]) | ||
− | |||
* [[Nimustine]] | * [[Nimustine]] | ||
* [[Ranimustine]] | * [[Ranimustine]] | ||
Line 154: | Line 154: | ||
| group3 = [[Alkylating antineoplastic agent#Nonclassical|Nonclassical]] | | group3 = [[Alkylating antineoplastic agent#Nonclassical|Nonclassical]] | ||
| list3 = | | list3 = | ||
+ | * [[Altretamine]] | ||
* ''[[Hydrazine]]s'' ([[Procarbazine]]<sup>#</sup>) | * ''[[Hydrazine]]s'' ([[Procarbazine]]<sup>#</sup>) | ||
+ | * [[Mitobronitol]] | ||
+ | * [[Pipobroman]] | ||
* ''[[Triazene]]s'' ([[Dacarbazine]]<sup>#</sup> | * ''[[Triazene]]s'' ([[Dacarbazine]]<sup>#</sup> | ||
* [[Temozolomide]]) | * [[Temozolomide]]) | ||
− | |||
− | |||
− | |||
| group4 = [[Intercalation (biochemistry)|Intercalation]] | | group4 = [[Intercalation (biochemistry)|Intercalation]] | ||
Line 220: | Line 220: | ||
| list3 = | | list3 = | ||
* [[Amsacrine]] | * [[Amsacrine]] | ||
− | |||
− | |||
− | |||
* [[Arsenic trioxide]] | * [[Arsenic trioxide]] | ||
* ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]<sup>#</sup>/[[Pegaspargase]]) | * ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]<sup>#</sup>/[[Pegaspargase]]) | ||
Line 229: | Line 226: | ||
* [[Elesclomol]]<sup>§</sup> | * [[Elesclomol]]<sup>§</sup> | ||
* [[Elsamitrucin]] | * [[Elsamitrucin]] | ||
+ | * [[Eribulin]] | ||
* [[Estramustine phosphate]] | * [[Estramustine phosphate]] | ||
* [[Etoglucid]] | * [[Etoglucid]] | ||
Line 237: | Line 235: | ||
* [[Oblimersen]]<sup>†</sup> | * [[Oblimersen]]<sup>†</sup> | ||
* [[Omacetaxine mepesuccinate]] | * [[Omacetaxine mepesuccinate]] | ||
− | * [[ | + | * [[Trabectedin]] |
+ | * ''[[Retinoid]]s'' ([[Alitretinoin]] | ||
+ | * [[Tretinoin]]<sup>#</sup>) | ||
}} | }} |
Revision as of 04:01, 2 April 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Chemotherapeutic agents|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Chemotherapeutic agents|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Chemotherapeutic agents|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.